Security Snapshot

Surgery Partners, Inc. - Common Stock (SGRY) Institutional Ownership

CUSIP: 86881A100

13F Institutional Holders and Ownership History from Q4 2015 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

179

Shares (Excl. Options)

156,841,353

Price

$15.45

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Create free account to save this page Review latest holder period
Type / Class
Equity / Common Stock
Symbol
SGRY on Nasdaq
Shares outstanding
129,870,130
Price per share
$11.92
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
156,841,353
Total reported value
$2,423,515,290
% of total 13F portfolios
0.01%
Share change
+5,322,298
Value change
+$56,378,763
Number of holders
179
Price from insider filings
$11.92
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • SGRY - Surgery Partners, Inc. - Common Stock is tracked under CUSIP 86881A100.
  • 179 institutions reported positions in Q4 2025.
  • 7 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 179 to 11 between Q4 2025 and Q1 2026.
  • Reported value moved from $2,423,515,290 to $4,061,165.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 179 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 86881A100?
CUSIP 86881A100 identifies SGRY - Surgery Partners, Inc. - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Surgery Partners, Inc. - Common Stock (SGRY) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BCPE Seminole Holdings LP 23% -0.62% $687,963,459 30,055,197 0% BCPE Seminole Holdings II Intermediate, LP 16 Jun 2025
JANUS HENDERSON GROUP PLC 10% +1% $282,111,656 +$1,767,274 13,036,583 +0.63% JANUS HENDERSON GROUP PLC 30 Sep 2025
Pentwater Capital Management LP 7.7% -16% $160,800,000 -$27,030,480 10,000,000 -14% Pentwater Capital Management LP 31 Dec 2025
KING STREET CAPITAL MANAGEMENT, L.P. 7.2% $202,116,085 9,339,930 King Street Capital Management, L.P. 30 Oct 2025
FMR LLC 5.1% -35% $100,999,508 -$53,831,666 6,537,016 -35% FMR LLC 31 Dec 2025
BlackRock, Inc. 4.4% $126,722,839 5,675,004 BlackRock, Inc. 31 Mar 2025
WELLINGTON MANAGEMENT GROUP LLP 0% -93% $4,783 -$156,297,520 217 -100% Wellington Management Group LLP 30 Jun 2025

As of 31 Dec 2025, 179 institutional investors reported holding 156,841,353 shares of Surgery Partners, Inc. - Common Stock (SGRY). This represents 121% of the company’s total 129,870,130 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Surgery Partners, Inc. - Common Stock (SGRY) together control 110% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Bain Capital Investors LLC 38% 49,946,972 0% 17% $771,680,717
JANUS HENDERSON GROUP PLC 10% 13,537,984 +3.8% 0.09% $209,161,693
KING STREET CAPITAL MANAGEMENT, L.P. 7.9% 10,229,730 +9.5% 22% $158,049,328
Pentwater Capital Management LP 7.7% 10,000,000 -14% 1.1% $154,500,000
UBS Group AG 6% 7,803,974 +111% 0.02% $120,571,398
VANGUARD GROUP INC 5.8% 7,565,905 -0.64% 0% $116,893,233
FMR LLC 5.1% 6,575,016 -37% 0.01% $101,583,994
BlackRock, Inc. 4.4% 5,691,031 +0.58% 0% $87,926,429
DIMENSIONAL FUND ADVISORS LP 3.8% 4,906,580 +0.95% 0.02% $75,808,355
Clearbridge Investments, LLC 3.3% 4,228,451 -0.33% 0.05% $65,329,565
GLENVIEW CAPITAL MANAGEMENT, LLC 3% 3,858,088 +51% 1.3% $59,607,460
Davidson Kempner Capital Management LP 1.8% 2,371,464 0.8% $36,639,119
GOLDMAN SACHS GROUP INC 1.5% 1,959,686 +528% 0% $30,277,149
GEODE CAPITAL MANAGEMENT, LLC 1.5% 1,943,449 +0.59% 0% $30,031,292
HSBC HOLDINGS PLC 1.5% 1,931,577 +104% 0.02% $30,151,357
STATE STREET CORP 1.4% 1,872,877 +0.99% 0% $28,935,950
NOMURA HOLDINGS INC 1.3% 1,720,159 +666% 0.2% $26,576,457
MORGAN STANLEY 0.88% 1,140,803 +14% 0% $17,625,407
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 0.85% 1,100,546 +5.3% 0% $17,003,436
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.76% 990,648 +6.4% 0% $15,305,512
VICTORY CAPITAL MANAGEMENT INC 0.59% 767,730 -3.4% 0.01% $11,861,429
RAYMOND JAMES FINANCIAL INC 0.54% 701,089 -16% 0% $10,831,820
Sea Cliff Partners Management, LP 0.52% 673,351 4.4% $10,403,273
NORTHERN TRUST CORP 0.5% 650,427 -9% 0% $10,049,097
MANUFACTURERS LIFE INSURANCE COMPANY, THE 0.49% 636,730 +0.09% 0.01% $9,837,479

Institutional Holders of Surgery Partners, Inc. - Common Stock (SGRY) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 340,811 $4,061,165 -$6,947,156 $11.92 11
2025 Q4 156,841,353 $2,423,515,290 +$56,378,763 $15.45 179
2025 Q3 151,406,137 $3,276,548,227 +$150,915,327 $21.64 197
2025 Q2 144,278,301 $3,207,216,275 +$96,557,278 $22.23 197
2025 Q1 139,643,559 $3,318,979,664 -$12,576,150 $23.75 204
2024 Q4 141,590,930 $2,997,289,879 +$19,892,991 $21.17 179
2024 Q3 137,923,250 $4,445,824,164 -$93,744,817 $32.24 184
2024 Q2 141,883,973 $3,375,681,923 +$113,712,319 $23.79 176
2024 Q1 136,901,931 $4,083,856,130 +$38,695,342 $29.83 178
2023 Q4 135,040,344 $4,320,033,899 +$5,014,626 $31.99 173
2023 Q3 134,819,136 $3,943,422,688 +$14,620,005 $29.25 164
2023 Q2 132,665,983 $5,968,815,677 +$151,844,535 $44.99 166
2023 Q1 130,043,383 $4,482,475,885 +$52,737,369 $34.47 151
2022 Q4 128,874,004 $3,590,376,282 +$982,835,667 $27.86 158
2022 Q3 93,927,789 $2,198,657,234 +$8,876,623 $23.40 130
2022 Q2 92,368,659 $2,671,774,444 +$36,680,603 $28.92 131
2022 Q1 90,688,899 $4,990,971,268 +$127,182,466 $55.05 142
2021 Q4 88,382,048 $4,720,313,294 +$406,797,201 $53.41 133
2021 Q3 81,052,523 $3,431,762,979 +$5,393,826 $42.34 133
2021 Q2 80,625,719 $5,370,104,650 +$1,564,829,794 $66.62 134
2021 Q1 57,619,712 $2,550,066,106 +$478,555,256 $44.26 119
2020 Q4 47,610,695 $1,381,528,968 -$18,908,903 $29.01 114
2020 Q3 47,513,254 $1,040,400,198 +$2,262,549 $21.90 99
2020 Q2 48,235,131 $557,972,424 +$27,624,491 $11.57 97
2020 Q1 46,997,441 $306,469,825 -$2,816,295 $6.53 83
2019 Q4 45,555,720 $715,530,434 -$26,037,507 $15.65 96
2019 Q3 47,534,648 $351,174,009 -$360,668 $7.38 85
2019 Q2 47,665,322 $387,959,241 -$59,203 $8.14 89
2019 Q1 47,815,066 $539,355,255 +$3,158,341 $11.28 79
2018 Q4 47,570,471 $465,711,541 -$7,762,616 $9.79 79
2018 Q3 47,408,913 $782,246,275 -$2,998,520 $16.50 78
2018 Q2 47,697,157 $710,694,056 -$6,654,865 $14.90 81
2018 Q1 48,029,358 $823,698,997 -$18,384,290 $17.15 80
2017 Q4 49,397,866 $597,717,238 +$37,469,838 $12.10 82
2017 Q3 46,315,129 $479,287,393 +$237,951,990 $10.35 88
2017 Q2 18,654,721 $424,409,724 -$4,197,428 $22.75 87
2017 Q1 18,970,601 $369,720,474 +$43,505,768 $19.50 84
2016 Q4 18,110,074 $287,048,179 -$13,797,345 $15.85 89
2016 Q3 18,657,986 $377,631,305 -$19,731,223 $20.24 84
2016 Q2 18,594,156 $332,832,883 +$30,979,903 $17.90 83
2016 Q1 17,330,334 $229,805,000 +$10,525,960 $13.26 62
2015 Q4 16,268,455 $333,415,137 +$333,382,137 $20.49 59